Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01572441 · ClinicalTrials.gov registry record
Parent-Adolescent Interactions and Adolescent Development
A clinical trial, sponsored by George Mason University.
- Completed
- Registry status
- 245
- Enrollment target
NCT01572441: Completed study, sponsored by George Mason University.
NCT01572441 is a clinical trial that has completed, run by George Mason University. The registered enrollment target is 245 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01572441 has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- 245 participants
- Enrollment target
Study Summary
The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.
Primary Outcome
Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2013-01-08 |
| Est. Completion | 2018-12-01 |
What the finished NCT01572441 record still lists
NCT01572441 is an observational study that tracks outcomes without assigning an intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01572441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01572441 about?
NCT01572441 is a clinical study titled "Parent-Adolescent Interactions and Adolescent Development". The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.
What is the current status of trial NCT01572441?
This trial is currently completed. The enrollment target is 245 participants. The study started on 2013-01-08. Estimated completion is 2018-12-01.
Who is sponsoring clinical trial NCT01572441?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI